FindTrial
Sign In

Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00206193
Enrollment
Unknown
Registered
2005-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2007-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion, Induced

Keywords

termination of pregnancy

Brief summary

The purpose of this study is to determine which medical treatment is the most effective to terminate a pregnancy.

Interventions

DRUGmifepristone
DRUGmisoprostol
DRUGsulprostone

Sponsors

Atrium Medical Center
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum

Inclusion criteria

* Pregnant women by whom a termination of pregnancy is desired.

Exclusion criteria

* Women with liver/kidney disease * Women on long-term use of corticosteroids (\> 6 months) * Cardiovascular problems * Therapy-resistant diabetic women * Therapy-resistant asthma/bronchitis * Thalassemia * Ulcerative colitis * Peptic ulcer disease * Glaucoma * Porphyria * Allergic reaction to prostaglandin or mifepristone * Women with a prior caesarian section or women with contractions at the start of the study

Countries

Netherlands

Contacts

Primary ContactSuzanne HW Vonken, Dr.
svonken@gmail.com003145-5766666
Backup ContactF Roumen, Dr.
003145-5766666

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026